<DOC>
	<DOCNO>NCT01185197</DOCNO>
	<brief_summary>Study objective : To investigate potential therapeutic efficacy enteric-coated mycophenolate sodium combine low-dose corticosteroid first-line treatment minimal change nephrotic syndrome ( MCNS ) .</brief_summary>
	<brief_title>MyforticÂ® Minimal Change Nephrotic Syndrome ( MCNS ) : Randomized Study</brief_title>
	<detailed_description>This prospective , open-label , randomized study patient present first time clinical diagnosis idiopathic MCNS proven renal biopsy assign either conventional standard-dose prednisolone monotherapy myfortic combine low-dose prednisolone treatment 6 month . Clinical response relapse rate within 6 month treatment cessation main outcome parameter .</detailed_description>
	<mesh_term>Nephrotic Syndrome</mesh_term>
	<mesh_term>Nephrosis</mesh_term>
	<mesh_term>Nephrosis , Lipoid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Male female 18 65 year age First histologic diagnosis MCNS Proteinuria &gt; 3.5 g/day Patients willing give write , informed consent Presence secondary cause MCNS History glomerular disease include MCNS eGFR &lt; 50 ml/min/1.73m2 Renal histology show pathology MCNS Female childbearing age unwilling practice effective contraception Patients simultaneously participate another study participate another study within last 30 day entry study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Minimal Change Nephrotic Syndrome</keyword>
	<keyword>Corticosteroid</keyword>
	<keyword>Mycophenolate</keyword>
	<keyword>Remission</keyword>
	<keyword>Safety</keyword>
</DOC>